AI assistant
Axogen, Inc. — Director's Dealing 2022
Aug 12, 2022
32414_dirs_2022-08-11_b05b1a30-13c2-46cd-881a-2a39c9447bde.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Axogen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2022-08-10
Reporting Person: Freitag Gregory Gene (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-08-10 | Common Stock | S | 8886 | $9.696 | Disposed | 365583 | Direct |
Footnotes
F1: The sale reported on the this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.
F2: The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $9.50 to $9.99 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.